Pharmacoeconomic Results Of Highly Innovative Drugs Approved For Temporary Reimbursement In The Czech Republic
Abstract
Authors
E Ornstova M Sebestianova T Mlcoch K Lamblova T Dolezal
E Ornstova M Sebestianova T Mlcoch K Lamblova T Dolezal
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now